Nachman Norwood & Parrott’s Merck MRK Stock Holding History

Nachman Norwood & Parrott’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$2.66M	Sell	33,912 -1,997	-6%	-$149K	0.27%	73
2021 Q1	$2.66M	Buy	35,909 +239	+0.7%	+$17.6K	0.29%	74
2020 Q4	$2.81M	Buy	35,670 +710	+2%	+$54.3K	0.33%	62
2020 Q3	$2.77M	Sell	34,960 -227	-0.6%	-$17.8K	0.37%	57
2020 Q2	$2.62M	Sell	35,187 -284	-0.8%	-$21.4K	0.43%	52
2020 Q1	$2.63M	Sell	35,471 -953	-3%	-$74.9K	0.53%	40
2019 Q4	$3.16M	Buy	36,424 +169	+0.5%	+$13.9K	0.52%	38
2019 Q3	$2.91M	Buy	36,255 +159	+0.4%	+$12.7K	0.52%	40
2019 Q2	$2.89M	Sell	36,096 -264	-0.7%	-$20.2K	0.52%	44
2019 Q1	$2.9M	Sell	36,360 -81	-0.2%	-$6.06K	0.54%	39
2018 Q4	$2.66M	Buy	+36,441	New	+$2.57M	0.55%	35

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Nachman Norwood & Parrott's MRK Position: Q2 2021 in Review

Nachman Norwood & Parrott reduced its Merck (MRK) stake by 5.6% in Q2 2021, selling an estimated $149K and leaving 33,912 shares worth $2.66M. The position accounts for 0.27% of the portfolio, ranked #73.

Nachman Norwood & Parrott first reported a position in MRK in Q4 2018 and has held it in 11 quarters since. The position peaked at $3.16M in Q4 2019. 2,674 funds tracked by Wall St. Rank hold MRK as of Q2 2021.

Nachman Norwood & Parrott held 33,912 shares of Merck worth $2.66M as of Q2 2021.
Nachman Norwood & Parrott sold 1,997 Merck shares in Q2 2021, an estimated $149K.
Merck made up 0.27% of Nachman Norwood & Parrott's portfolio in Q2 2021, its #73 holding.
Nachman Norwood & Parrott first reported a position in Merck in Q4 2018 and has held it in 11 quarters since.
Nachman Norwood & Parrott's Merck position peaked at $3.16M in Q4 2019.
2,674 funds tracked by Wall St. Rank held Merck as of Q2 2021.

Based on Nachman Norwood & Parrott's 13F filing for Q2 2021, filed 13 Aug 2021.